Shanghai Eliv Pharmaceutical Co., Ltd. was founded in 2011. Eliv Pharma focus on R&D and production of APIs and intermediates. The major members in the team have Ph.D. or MSEE degrees from prominent universities in China and overseas. Except for first-class production and advanced research facilities, Elivpharma has a comprehensive management system and the production base in Nantong passed the c-GMP certification, passed the audit of FDA and Japanese Ministry of labor.

Eliv pharma cooperate with domestic famous design institutes to promote the enterprises growing rapidly, boost the existing and developing ability at the market competition. Now, Eliv pharma’s products have been used in cardiovascular and cerebrovascular, anti-cancer, anti-Virus, respiratory system and so on.